|
|
|
Insider
Information: |
Bolzon Bradley J Phd |
Relationship: |
Director, 10% Owner |
City: |
Menlo Park |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
21,851 |
|
Indirect Shares
|
13,354,534 |
|
|
Direct
Value |
$113,407 |
|
|
Indirect Value
|
$87,225,938 |
|
|
Total
Shares |
13,376,385 |
|
|
Total
Value |
$87,339,345 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-15.0%
|
-33.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2006-05-15 |
13,713 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Flexion Therapeutics Inc |
FLXN |
Director, 10% Owner |
|
0 |
2014-02-18 |
3,206,807 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Phaserx, Inc. |
PZRX |
10% Owner |
|
0 |
2016-05-23 |
1,931,094 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Crispr Therapeutics Ag |
CRSP |
Director |
2021-06-29 |
0 |
2021-07-19 |
498,558 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Black Diamond Therapeutics, Inc. |
BDTX |
Director, 10% Owner |
2020-12-14 |
21,851 |
2020-12-14 |
5,606,424 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Monte Rosa Therapeutics, Inc. |
GLUE |
Director, 10% Owner |
2021-06-28 |
0 |
2021-06-28 |
2,097,938 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
134 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-18 |
4 |
AS |
$86.87 |
$263,636 |
I/I |
(3,035) |
518,190 |
0 |
% |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-11-06 |
4 |
AS |
$33.13 |
$102,698 |
I/I |
(3,100) |
5,686,909 |
0 |
% |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,780 |
8,707 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-09 |
4 |
AS |
$33.67 |
$127,933 |
I/I |
(3,800) |
5,737,027 |
0 |
% |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-11-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,935 |
19,569 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-11-17 |
4 |
AS |
$33.05 |
$138,611 |
I/I |
(4,194) |
4,933,927 |
0 |
% |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-19 |
4 |
AS |
$33.43 |
$141,513 |
I/I |
(4,233) |
5,707,536 |
0 |
% |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-11-13 |
4 |
AS |
$33.31 |
$151,984 |
I/I |
(4,500) |
4,937,809 |
0 |
% |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-07 |
4 |
A |
$0.00 |
$0 |
I/I |
5,312 |
4,131 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,456 |
15,634 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-14 |
4 |
AS |
$33.09 |
$182,031 |
I/I |
(5,501) |
5,721,445 |
0 |
% |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-08-10 |
4 |
AS |
$33.04 |
$205,398 |
I/I |
(6,217) |
6,803,922 |
0 |
% |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-11-09 |
4 |
AS |
$33.06 |
$208,250 |
I/I |
(6,300) |
5,681,344 |
0 |
% |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-07-27 |
4 |
A |
$0.00 |
$0 |
I/I |
6,495 |
1,177 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-12-16 |
4 |
AS |
$147.00 |
$1,095,089 |
I/I |
(7,352) |
339,834 |
0 |
% |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
7,391 |
7,391 |
0 |
- |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-08-11 |
4 |
AS |
$33.08 |
$250,591 |
I/I |
(7,575) |
6,797,230 |
0 |
% |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-12-16 |
4 |
AS |
$147.00 |
$1,139,177 |
D/D |
(7,648) |
0 |
0 |
% |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-26 |
4 |
AS |
$33.30 |
$269,867 |
I/I |
(8,103) |
5,700,378 |
0 |
% |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-10-16 |
4 |
AS |
$33.57 |
$292,520 |
I/I |
(8,713) |
5,711,275 |
0 |
% |
|
BDTX |
Black Diamond Therapeutic... |
Director |
|
2020-11-05 |
4 |
AS |
$33.15 |
$293,287 |
I/I |
(8,848) |
5,689,647 |
0 |
% |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-09-16 |
4 |
AS |
$86.98 |
$779,777 |
I/I |
(8,965) |
521,225 |
0 |
% |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2018-05-08 |
4 |
AS |
$50.16 |
$467,067 |
D/D |
(9,241) |
34,745 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-06-22 |
4 |
AS |
$72.51 |
$725,069 |
I/I |
(10,000) |
584,190 |
0 |
% |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2020-06-23 |
4 |
AS |
$75.35 |
$753,453 |
I/I |
(10,000) |
574,190 |
0 |
% |
|
134 Records found
|
|
Page 2 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|